IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 289 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $547,000 | -42.7% | 12,174 | -27.9% | 0.04% | -44.6% |
Q4 2020 | $955,000 | +25.0% | 16,895 | +4.9% | 0.06% | +10.2% |
Q3 2020 | $764,000 | -22.1% | 16,110 | -3.2% | 0.06% | -31.4% |
Q2 2020 | $981,000 | +12.9% | 16,640 | -9.5% | 0.09% | -13.1% |
Q1 2020 | $869,000 | -30.1% | 18,390 | -10.7% | 0.10% | -17.5% |
Q4 2019 | $1,244,000 | +0.8% | 20,590 | 0.0% | 0.12% | -9.1% |
Q3 2019 | $1,234,000 | -13.2% | 20,590 | -6.9% | 0.13% | -13.2% |
Q2 2019 | $1,421,000 | -20.3% | 22,110 | +0.7% | 0.15% | -22.8% |
Q1 2019 | $1,782,000 | +77.7% | 21,960 | +18.3% | 0.20% | +48.1% |
Q4 2018 | $1,003,000 | +141.1% | 18,560 | +130.3% | 0.13% | +171.4% |
Q3 2018 | $416,000 | -23.8% | 8,060 | -38.4% | 0.05% | -30.0% |
Q2 2018 | $546,000 | -9.8% | 13,095 | -4.6% | 0.07% | -9.1% |
Q1 2018 | $605,000 | -13.7% | 13,720 | -1.6% | 0.08% | -16.3% |
Q4 2017 | $701,000 | -3.8% | 13,945 | -3.0% | 0.09% | -3.2% |
Q3 2017 | $729,000 | -10.4% | 14,370 | -10.2% | 0.10% | -12.8% |
Q2 2017 | $814,000 | +18.1% | 15,995 | -6.7% | 0.11% | +14.7% |
Q1 2017 | $689,000 | -32.8% | 17,145 | -20.0% | 0.10% | -34.9% |
Q4 2016 | $1,025,000 | -13.0% | 21,420 | -33.4% | 0.15% | -15.1% |
Q3 2016 | $1,178,000 | -12.7% | 32,160 | -44.5% | 0.17% | -12.2% |
Q2 2016 | $1,350,000 | -70.4% | 57,983 | -48.6% | 0.20% | -71.0% |
Q1 2016 | $4,568,000 | -34.4% | 112,797 | +0.2% | 0.68% | -40.8% |
Q4 2015 | $6,968,000 | – | 112,522 | – | 1.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |